© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
About N/A of shares are held by financial institutions. TRIUMPH CAPITAL MANAGEMENT is the top corporate investor, holding 17K shares valued at $3.00. A 0.01% stake in Humanigen, Inc. is owned by the company. TRIUMPH CAPITAL MANAGEMENT owns 17K shares valued at $20.00, which translates its holding of 0.01% of the stake in the company.
Among the HGEN insiders holding of N/A of the stake in company, NOMIS BAY LTD., 10 percent owner, holds the largest shares of 5.38M. CHEVAL HOLDINGS, LTD., , is the second largest HGEN insider with ownership of 1.08M shares. CHAPPELL DALE, Chief Scientific Officer, stands third with possession of 1.04M shares of that stake.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own HGEN shares is N/A, representing N/A of the company's common stock.
CIBC PRIVATE WEALTH GROUP, LLC, in the last quarter, reduced its stake in HGEN by -100% restricting it's holding to 0 shares of worth nearly -. DAYMARK WEALTH PARTNERS, LLC also lessened -100% of the HGEN shares from its portfolio, reducing its holding to 0 shares of worth -. BANK OF AMERICA CORP /DE/ also shunned HGEN shares holding by -100% last quarter which brought its holding to 0 shares worth -.
As per its latest 13F filing, N/A increased its stake in HGEN by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of HGEN to its portfolio, raising its holding to - shares of worth -. N/A also increased its HGEN shares holding by N/A which brought its holding to - shares worth -.
The insider with the most stakes in HGEN is NOMIS BAY LTD. , 10 percent owner at the company. Additionally, HGEN stock is highly held by Cheval Holdings, Ltd. and Chief Scientific Officer Chappell Dale among others.
Company executives, directors, and other insiders own N/A percent of Humanigen, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which HGEN insiders have sold stock, totaling 0 shares. Insiders that have sold shares include CHAPPELL DALE, DURRANT CAMERON, and JORDAN EDWARD P..
There have been 0 transaction(s) during the past 6-months in which Humanigen, Inc. insiders have bought stock, totalling 0 shares
Around 0 Humanigen, Inc. shares are held by insiders, which represents about N/A of HGEN stock.
HGEN 10 percent owner, NOMIS BAY LTD. holds the largest portfolio of the company's shares. HGEN shares owned by NOMIS total nearly 5.38 million.
TRIUMPH CAPITAL MANAGEMENT is the largest institutional owner in HGEN which holds 17 thousand shares worth $3.00 or 0.01% of the total HGEN shares outstanding followed by TRIUMPH CAPITAL MANAGEMENT with ownership of 17 thousand shares representing 0.01% of the HGEN ownership. CIBC PRIVATE WEALTH GROUP, LLC is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the HGEN is concerned, it is a stock which is optionable.
Number of HGEN shares short is N/A. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, N/A shares of HGEN are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, HGEN has N/A shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for HGEN is N/A.